Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Targeting of prestigious publication — and perhaps others — could signal a coming clash between journals and the Trump ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

Wildfire smoke can have immediate and lasting effects on health, according to Dr. Sophia Meziani, an emergency medicine ...

UMass Memorial Health said its mobile integrated healthcare program reduced emergency room visits and saved up to $1.8 ...

New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...

Updating the state’s solar tax credit will make clean energy more accessible and affordable for low-income New Yorkers.

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

“Fairfield County has certainly the worst ozone pollution, or smog pollution, in all of New England,” Canovi said. Ozone smog ...